CASSS - An International Separation Science Society

CMC Strategy Forum Japan 2012

Monday, December 03, 2012 - Tuesday, December 04, 2012


On behalf of the CASSS Board of Directors and the CMC Strategy Forum Advisory Committee, I would like to extend to you a warm welcome to the inaugural meeting of the CMC Strategy Forum Japan 2012. This will be the first time that the CMC Forum series will move to Asia with Tokyo being the first location chosen. 

We are very pleased that with the strong support from the Pharmaceuticals and Medical Devices Agency (PMDA, Japan), as well as the Japan Pharmaceutical Manufacturers Association (JPMA), and with the continued sponsorship by CASSS and the United States Food and Drug Administration, that we are launching the CMC Strategy Forum Japan 2012. The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia and will feature an opening regulatory session that will include presentations from PMDA, FDA, EMA, KFDA, SFDA, as well as HSA. The technical sessions will include discussions on biosimilars, glycosylation control and structure-function relationship, as well as a brief session on QbD for biologics. 

With this exciting program, I would like to extend to you an invitation to attend and participate actively in making this landmark meeting a great success. 

Wassim Nashabeh
CMC Strategy Forum Advisory Committee



The CMC Strategy Forum Japan is supported by the Pharmaceuticals and Medical Devices Agency, Japan and the
Japan Pharmaceutical Manufacturers Assosciation
 
   

 

CASSS - An International Separation Science Society   |   5900 Hollis Street, Suite R3 Emeryville, CA 94608   |   Ph: 510.428.0740   |   Fax: 510.428.0741

Privacy Policy © Copyright 2013, All Rights Reserved - CASSS